Skip to main content
Clinical Trials/NCT02667665
NCT02667665CompletedNot Applicable

Verification Study and Reactivity Study for the Validity of a Novel Dementia Rating Scale "QUick QUestion Scale" for Alzheimer's Disease Dementia

Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan1 site in 1 country240 target enrollmentStarted: February 19, 2016Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
240
Locations
1
Primary Endpoint
NPI-Caregiver Distress. Scale(NPI-D)

Study Overview

Brief Summary

Examine the construct validity, the test-retest reliability, the concurrent validity with the standard dementia rating scales and the reactivity of a novel dementia rating scale "QuQu scale: QUick QUestion scale" final for the evaluation of patients with Alzheimer's Disease Dementia and Mild Cognitive Impairment.

Study Design

Study Type
Observational
Observational Model
Other
Time Perspective
Prospective

Eligibility Criteria

Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Alzheimer's Disease Dementia and patients with cognitive concern without Dementia
  • Written Informed consent by each subject and/or a legal representative, and study informant. If the doctor decides that the patient has no trouble in understanding this study, the written informed consent of a legal representative may be exempted. If not, this study needs a written informed consent by a legal representative and the patient except the case where the consent is hardly obtained due to the progression of the disease.

Exclusion Criteria

  • patients with other types of dementia (e.g. vascular dementia, Levy body dementia, frontotemporal dementia)
  • patients with other diseases which cause secondary dementia prior to Alzheimer's Disease Dementia
  • patients with other severe neurological disease or psychiatric disorder without Alzheimer's Disease Dementia
  • patients with other medical conditions where the investigators determine that it is inappropriate for the subject of this study (e.g. inappropriate for the evaluation of dementia rating scale)

Outcomes

Primary Outcomes

NPI-Caregiver Distress. Scale(NPI-D)

Time Frame: 12 weeks

Clinical Dementia Rating

Time Frame: 12 weeks

QuQu scale candidate

Time Frame: 12 weeks

Mini-Mental State Examination (MMSE)

Time Frame: 12 weeks

Disability Assessment for Dementia (DAD)

Time Frame: 12 weeks

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials

Verification Study and Reactivity Study... | Clinical Trial